IgA Nephropathy: Seven Resources for Information and Support

A diagnosis of IgA nephropathy (IgAN) can raise questions about care, costs, and what comes next. The condition affects about 200,000 people in the United States, and finding information tailored to it may take effort. These seven resources offer different kinds of support, from peer connections and appointment preparation to financial assistance and clinical trial listings. Each serves a different need, so the most useful starting point depends on the questions you have.

Education and patient connections

IgA Nephropathy Foundation. Founded by Bonnie Schneider and her husband, Ed, after their son was diagnosed at age 13 in 2004, this organization focuses exclusively on people with IgAN and their care partners. It supports research and offers monthly groups for patients and caregivers. Its ambassador program connects people with trained advocates in their area, while SPARK, a two-day annual symposium, brings patients, families, and experts together to discuss the disease.

The foundation’s IgAN Hope Patient Registry lets people share information about their health and experiences to support research. Participants can receive updates on findings and clinical trials. The organization’s website also lists disease-specific resources, events, and research news.

National Kidney Foundation (NKF). NKF covers kidney health broadly, with a dedicated IgAN section that includes patient stories and educational tools. Its free IgA Nephropathy Patient Journey explains test results and treatment options, and suggests questions to discuss with a healthcare provider. NKF PEERS offers one-on-one conversations with trained mentors who have personal experience with kidney disease. NKF Cares is a helpline for questions about kidney disease, transplantation, and living donation. The organization also points visitors to online communities and offers workshops and in-person events.

American Association of Kidney Patients (AAKP). AAKP has supported kidney patients and families since 1969. Its website includes an IgAN information section and a directory for finding patient and caregiver groups by state. Virtual groups cover topics including transplantation, dialysis, and caregiving. Free resources such as RenaLife magazine, email newsletters, and webinars provide ongoing education. AAKP’s Veterans Health Initiative addresses kidney health challenges faced by veterans and their families.

Practical and financial help

American Kidney Fund (AKF). IgAN can bring transportation, medication, and other out-of-pocket healthcare costs. AKF offers need-based financial assistance to eligible patients for expenses that may include insurance premiums, transportation, and prescription medicines. Its educational materials cover multiple kidney conditions, including IgAN, and its website features patient stories and resources for IgAN Awareness Day in May.

AKF also provides a clinical trial search tool for open IgAN studies, with information about what taking part can involve. An appointment guide can help patients organize questions for a medical visit. The Rare Kidney Disease Action Network connects people with kidney disease and caregivers who want to share their experiences in support of policy changes; members can receive training on communicating with state and federal officials.

NephCure. This organization focuses on rare kidney diseases that cause protein in the urine, including IgAN. Its resources cover diagnosis, treatment options, nutrition, mental health, and finding kidney specialists. Through its patient navigation program, trained staff can help people look for care, explore genetic testing or a second opinion, understand insurance issues, and find medication assistance programs.

NephCure leads the IgAN Alliance, bringing together patients, caregivers, healthcare professionals, and advocacy organizations to improve early diagnosis and care. Its website also lists clinical trial information. Adults can join virtual support groups, parents have separate groups, and an online community gives patients and families a place to exchange experiences. NephCure hosts Rare Kidneys on the Hill Day in Washington, DC, where participants discuss research and coverage with lawmakers; upcoming events are listed on its site.

National Organization for Rare Disorders (NORD). Some people with IgAN may qualify for NORD programs. Its RareCare Assistance Program can help eligible patients with out-of-pocket expenses such as insurance premiums, deductibles, copays, and coinsurance. NORD may also help people without insurance access coverage. The Rare Disease Educational Support Program may cover conference or workshop registration and some travel costs. Its Rare Caregiver Respite Program offers financial help for short-term caregiving support, giving family caregivers time for personal needs or rest.

Finding and considering clinical trials

ClinicalTrials.gov. This free, searchable database lists clinical trials and other studies, including research on IgAN treatments. The source describes full approval for three targeted therapies: budesonide (Tarpeyo), sparsentan (Filspari), and iptacopan (Fabhalta). It also notes accelerated approval for atrasentan (Vanrafia). These treatment developments make it useful to understand what studies are exploring, but a trial listing does not mean a treatment is suitable for a particular person.

Search filters can narrow results by condition, location, age, and other factors. Listings describe a study’s purpose, eligibility criteria, what participation involves, and how to contact the research team. Trials may offer access to treatments being studied and involve close monitoring, but participation is a personal decision with potential demands and uncertainties. Anyone interested in a study should discuss it with their healthcare team, which can help assess whether it fits their circumstances.

Choosing a starting point

For peer support, the foundation, NKF, NephCure, and AAKP offer ways to connect with others. AKF and NORD may be useful when costs are a concern, while NKF’s patient guide and AKF’s appointment resource can help prepare for a medical conversation. ClinicalTrials.gov provides study listings, and NephCure and AKF also offer trial-related information.

These organizations provide different services, and eligibility rules apply to some forms of financial assistance. A doctor or pharmacist can help answer questions about treatment options and whether a clinical study is worth discussing. The right resource is the one that addresses the need at hand, whether that’s clear information, practical help, or a conversation with someone who understands life with IgAN.